Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sample size calculations based on generalized estimating equations for population pharmacokinetic experiments.

Kayode Ogungbenro1, Leon Aarons, Gordon Graham

  • 1Centre for Applied Pharmacokinetic Research, School of Pharmacy and Pharmaceutical Sciences, The University of Manchester, Manchester, UK. kayode.ogungbenro@manchester.ac.uk

Journal of Biopharmaceutical Statistics
|April 6, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advancing quantitative clinical pharmacology competencies in Francophone Africa through an on-line learning framework.

Journal of pharmacokinetics and pharmacodynamics·2026
Same author

Application of modelling of cell monolayer permeation data to generate input parameters compatible with in vitro-in vivo translation of blood-brain-barrier disposition of drugs.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2026
Same author

Population Physiologically-Based Pharmacokinetic Modeling to Determine Ontogeny: A Quantitative Clinical Pharmacology Example in Pediatric Rare Disease.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Population pharmacokinetics and dose-response relationships of mitoxantrone in children with acute myeloid leukaemia.

British journal of clinical pharmacology·2026
Same author

Virtual Twin-PBPK Modelling: A Step Toward Precision Dosing in Patients with Obesity.

The AAPS journal·2026
Same author

A prospective cohort feasibility study of real-time beta-lactam antimicrobial therapeutic drug monitoring in critically ill patients with lower respiratory infection: The TDM-TIME study.

Journal of the Intensive Care Society·2025

This study introduces a new method for determining sample sizes in pharmacokinetic studies using mixed effects models. The approach is adaptable for complex designs, ensuring robust hypothesis testing for pharmacokinetic parameters.

Area of Science:

  • Pharmacokinetics and Pharmacometrics
  • Statistical Modeling
  • Clinical Trial Design

Background:

  • Accurate sample size calculation is crucial for the efficiency and validity of pharmacokinetic studies.
  • Existing methods may not adequately address the complexities of nonlinear mixed effects models and repeated measures.
  • Hypothesis testing in pharmacokinetics requires robust statistical frameworks.

Purpose of the Study:

  • To develop and validate a method for calculating sample size in pharmacokinetic studies analyzed with mixed effects models.
  • To adapt existing sample size calculation techniques for repeated measurement data to nonlinear models.
  • To provide a flexible method applicable to unequal group allocations and varied sampling schedules.

Main Methods:

  • Modified a sample size calculation method for generalized estimating equations (GEE) for nonlinear models.

Related Experiment Videos

  • Employed a marginal model for population pharmacokinetics by linearizing the structural model.
  • Utilized the Wald test for hypothesis testing of pharmacokinetic parameters.

    • Main Results:

    • The proposed method demonstrated good agreement in Monte Carlo simulations across various scenarios.
    • The method accommodates unequal subject allocation between groups.
    • It accounts for differing blood sampling schedules required for different patient groups.

    Conclusions:

    • The presented method offers a versatile approach for sample size determination in pharmacokinetic studies.
    • It is suitable for complex designs involving nonlinear mixed effects models and repeated measures.
    • The method supports robust hypothesis testing for pharmacokinetic parameters.